Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002331 · ClinicalTrials.gov registry record · NA
The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS
A NA study of HIV Infections and Mycobacterium Avium-intracellular Infection, sponsored by Abbott.
- Completed
- Registry status
- NA
- Development phase
- 18
- Study locations
NCT00002331 is a NA study of HIV Infections and Mycobacterium Avium-intracellular Infection that has completed, run by Abbott. The trial reports 18 study locations across 12 states.
The verdict
NCT00002331, a NA study of HIV Infections and Mycobacterium Avium-intracellular Infection, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- NA
- Development phase
- 18
- Study locations
Study Summary
PRIMARY: To assess the tolerability of the combination regimen of clarithromycin plus ethambutol with or without clofazimine in patients with disseminated Mycobacterium avium Complex (dMAC). SECONDARY: To determine the proportion of patients achieving a sterile blood culture along with the time required to achieve it. To determine the duration of bacteriological response, defined as length of time that blood cultures remain sterile.
Conditions Studied
Interventions
- DRUG Clofazimine
- DRUG Clarithromycin
- DRUG Ethambutol hydrochloride
Study Locations (18)
California
- Kaiser Permanente Med Ctr - Los Angeles
- UCD Med Ctr - Sacramento
- Kaiser Permanente Med Ctr - San Francisco
- Santa Clara Valley Med Ctr - San Jose
Florida
- Dr Margaret Fischel - Miami
- Saint Joseph's Hosp / Infectious Disease Rsch Institute - Tampa
New York
- Beth Israel Med Ctr - New York
- Mount Sinai Med Ctr - New York
Texas
- Univ of Texas Southwestern Med Ctr of Dallas - Dallas
- Houston Veterans Administration Med Ctr - Houston
District of Columbia
- George Washington Univ Med Ctr - Washington D.C.
Illinois
- Rush Presbyterian - Saint Luke's Med Ctr - Chicago
Louisiana
- Tulane Univ Med School - New Orleans
Maryland
- Johns Hopkins Univ School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Start Date | 1994-01 |
| Est. Completion | 1995-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002331
The ClinicalTrials.gov registry entry for NCT00002331 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 3 interventions - of which Clofazimine is the first listed.
NCT00002331 reports 18 study locations spanning 12 distinct geographic areas - top geographies include California, Florida, New York.
Frequently Asked Questions
What is clinical trial NCT00002331 about?
NCT00002331 is a clinical study titled "The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS". PRIMARY: To assess the tolerability of the combination regimen of clarithromycin plus ethambutol with or without clofazimine in patients with disseminated Mycobacterium avium Complex (dMAC). SECONDARY: To determine the proportion of patients achieving a sterile blood culture along with the time req...
What is the current status of trial NCT00002331?
This trial is currently completed. It is a NA study. The study started on 1994-01. Estimated completion is 1995-03.
What conditions does trial NCT00002331 study?
This clinical trial studies the following conditions: HIV Infections, Mycobacterium Avium-intracellular Infection.
What interventions are being tested in trial NCT00002331?
The interventions under investigation include: Clofazimine (DRUG), Clarithromycin (DRUG), Ethambutol hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00002331?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002331 being conducted?
This trial has 18 study locations across California, District of Columbia, Florida, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Explore more on PlainTrial
HIV Infections
All registered trials for this condition
Mycobacterium Avium-intracellular Infection
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.